Funds › Knoll Capital Management, LLC
Knoll Capital Management, LLC
13F for Q2 2026, filed Aug 14, 2026. 37 positions worth $179.3M.Managers with more than $100 million in US-listed stocks list their holdings each quarter, within 45 days of quarter end. Long positions only: no short sales or cash.
Ask your AI about this
Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:
Using 13F.ai, what are the biggest new, added, trimmed and exited positions of Knoll Capital Management, LLC in the latest 13F quarter?
Using 13F.ai, how has Knoll Capital Management, LLC's portfolio concentration changed over the last four quarters?
Using 13F.ai, which of Knoll Capital Management, LLC's top holdings have also been bought by insiders recently?
Connect your AI · Plans and the 7-day free trial (card required)
Holdings, Q2 2026
Largest first. Common shares only.
| # | The fund's own figures at the end of the quarter. A report can be up to 45 days old when it is filed. Options and bonds are not counted here. | Filing | ||||
|---|---|---|---|---|---|---|
| 1 | MGTX MeiraGTx Holdings plc | 1.25M | $16.9M | 9.4% | Unchanged | 13F ↗ |
| 2 | PHYS Sprott Physical Gold Trust ETV · Physical Gold Tr | 387,055 | $11.7M | 6.5% | Unchanged | 13F ↗ |
| 3 | ALDX Aldeyra Therapeutics, Inc. | 5.48M | $11.7M | 6.5% | Unchanged | 13F ↗ |
| 4 | OCUL Ocular Therapeutix, Inc. | 1.15M | $11.3M | 6.3% | +91.6% | 13F ↗ |
| 5 | RGLD Royal Gold, Inc. | 52,750 | $10.5M | 5.9% | Unchanged | 13F ↗ |
| 6 | ENTX Entera Bio Ltd. | 5.88M | $10.4M | 5.8% | Unchanged | 13F ↗ |
| 7 | NUVB Nuvation Bio Inc. | 1.60M | $9.1M | 5.1% | +6.7% | 13F ↗ |
| 8 | AEM Agnico Eagle Mines Limited | 52,750 | $8.2M | 4.6% | Unchanged | 13F ↗ |
| 9 | Seabridge Gold Inc Com *D* | 317,003 | $8.2M | 4.6% | Unchanged | 13F ↗ |
| 10 | KGC Kinross Gold Corporation | 320,000 | $7.6M | 4.2% | Unchanged | 13F ↗ |
| 11 | OR OR Royalties Inc. | 225,000 | $7.1M | 4.0% | Unchanged | 13F ↗ |
| 12 | SSRM SSR Mining Inc. | 245,000 | $6.9M | 3.9% | Unchanged | 13F ↗ |
| 13 | FNV Franco-Nevada Corporation | 32,000 | $6.7M | 3.7% | Unchanged | 13F ↗ |
| 14 | CGAU Centerra Gold Inc. | 359,000 | $5.7M | 3.2% | Unchanged | 13F ↗ |
| 15 | BAH Booz Allen Hamilton Holding Corporation | 13,000 | $5.7M | 3.2% | Unchanged | 13F ↗ |
| 16 | ELTX Elicio Therapeutics, Inc. · Lst Equity Option | 1.21M | $4.7M | 2.6% | +92.1% | 13F ↗ |
| 17 | ABVX Abivax SA · ADR | 35,000 | $4.7M | 2.6% | New | 13F ↗ |
| 18 | PAAS Pan American Silver Corp. · Comm | 100,035 | $4.5M | 2.5% | Unchanged | 13F ↗ |
| 19 | PSLV Sprott Physical Silver Trust ETV · Physical Silver | 222,160 | $4.2M | 2.3% | Unchanged | 13F ↗ |
| 20 | TFPM Triple Flag Precious Metals Corp. | 115,000 | $3.4M | 1.9% | Unchanged | 13F ↗ |
| 21 | ABEO Abeona Therapeutics Inc. | 485,515 | $3.0M | 1.7% | Unchanged | 13F ↗ |
| 22 | GROY Gold Royalty Corp. | 1.00M | $2.8M | 1.5% | Unchanged | 13F ↗ |
| 23 | NEWP New Pacific Metals Corp. | 485,000 | $1.9M | 1.1% | Unchanged | 13F ↗ |
| 24 | iShares Tr Us Aer Def Etf | 7,650 | $1.9M | 1.0% | Unchanged | 13F ↗ |
| 25 | PM Philip Morris International Inc | 10,000 | $1.8M | 1.0% | Unchanged | 13F ↗ |
| 26 | CDE Coeur Mining, Inc. | 96,132 | $1.6M | 0.9% | Unchanged | 13F ↗ |
| 27 | AGI Alamos Gold Inc. | 50,000 | $1.5M | 0.8% | Unchanged | 13F ↗ |
| 28 | WPM Wheaton Precious Metals Corp | 12,500 | $1.4M | 0.8% | Unchanged | 13F ↗ |
| 29 | NOC Northrop Grumman Corporation | 2,165 | $1.1M | 0.6% | Unchanged | 13F ↗ |
| 30 | ELE Elemental Royalty Corporation | 50,000 | $873.0K | 0.5% | Unchanged | 13F ↗ |
| 31 | VMET Versamet Royalties Corporation | 66,621 | $820.7K | 0.5% | Unchanged | 13F ↗ |
| 32 | DC Dakota Gold Corp. | 122,921 | $523.6K | 0.3% | Unchanged | 13F ↗ |
| 33 | AMRZ Amrize Ltd | 9,175 | $489.0K | 0.3% | Unchanged | 13F ↗ |
| 34 | ALT Altimmune, Inc. | 160,000 | $486.4K | 0.3% | Unchanged | 13F ↗ |
| 35 | PHAR Pharming Group N.V. · ADR | 4,091 | $56.8K | <0.1% | +0.8% | 13F ↗ |
| 36 | Orgenesis, Inc | 50,623 | $20.8K | <0.1% | Unchanged | 13F ↗ |
| 37 | Biohaven Pharmactl Holding Co | 2.33M | $15 | <0.1% | Unchanged | 13F ↗ |
Changes since Q1 2026
1 new, 4 added to, 0 trimmed, 1 exited, 32 unchanged. By estimated dollars.
New positions (1)
| Position | Shares | Change | Est. dollars |
|---|---|---|---|
| ABVX Abivax SA · ADR | 35,000 | New | $4.7M |
Added to (4)
Trimmed (0)
None this quarter.
Exited (1)
| Position | Shares | Change | Est. dollars |
|---|---|---|---|
| CRDL Cardiol Therapeutics Inc. | 100,000 | Exited | -$135.0K |
The 10 largest of each, by estimated dollars: shares changed times the later report's price. Index tracking, splits and mergers move positions too.
Compare two quarters
Pick any two quarters: what is new, added to, trimmed or exited. Premium plan.
Reported value by quarter
Value and number of positions at the end of each quarter.
Loading…
Largest positions in earlier quarters
Pick a quarter to see what the fund's biggest positions were then.
Loading…
Ten largest positions
By value, Q2 2026.
Filings
Most recent first, up to 80. An amendment can replace a report or add holdings to it. All 13F filings
Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer